Literature DB >> 18974117

Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein.

James W Gallagher1, Neil Kubica, Scot R Kimball, Leonard S Jefferson.   

Abstract

Eukaryotic initiation factor 2B (eIF2B), a five-subunit guanine nucleotide exchange factor, plays a key role in the regulation of mRNA translation. Expression of its epsilon-subunit is specifically up-regulated in certain conditions associated with increased cell growth. Therefore, the purpose of the present study was to examine the effect of repressing eIF2Bepsilon expression on growth rate, protein synthesis, and other characteristics of two tumorigenic cell lines that display up-regulated expression of the epsilon-subunit. Experiments were designed to compare spontaneously transformed fibroblasts to transformed mouse embryonic fibroblasts infected with a lentivirus containing a short hairpin RNA directed against eIF2Bepsilon. Cells expressing the short hairpin RNA displayed a reduction in eIF2Bepsilon abundance to 30% of the value observed in uninfected transformed mouse embryonic fibroblasts, with no change in the expression of any of the other four subunits. The repression of eIF2Bepsilon expression was accompanied by reductions in guanine nucleotide exchange factor activity and global rates of protein synthesis. Moreover, repressed eIF2Bepsilon expression led to marked reductions in cell growth rate in culture, colony formation in soft agar, and tumor progression in nude mice. Similar results were obtained in MCF-7 human breast cancer cells in which eIF2Bepsilon expression was repressed through transient transfection with a small interfering RNA directed against the epsilon-subunit. Overall, the results support a role for eIF2Bepsilon in the regulation of cell growth and suggest that it might represent a therapeutic target for the treatment of human cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974117      PMCID: PMC2664734          DOI: 10.1158/0008-5472.CAN-08-1042

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

2.  Ras mediates translation initiation factor 4E-induced malignant transformation.

Authors:  A Lazaris-Karatzas; M R Smith; R M Frederickson; M L Jaramillo; Y L Liu; H F Kung; N Sonenberg
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

3.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

4.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR.

Authors:  S H Kim; A P Forman; M B Mathews; S Gunnery
Journal:  Oncogene       Date:  2000-06-22       Impact factor: 9.867

5.  The translational activator GCN3 functions downstream from GCN1 and GCN2 in the regulatory pathway that couples GCN4 expression to amino acid availability in Saccharomyces cerevisiae.

Authors:  E M Hannig; N P Williams; R C Wek; A G Hinnebusch
Journal:  Genetics       Date:  1990-11       Impact factor: 4.562

6.  Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B.

Authors:  A Sudhakar; A Ramachandran; S Ghosh; S E Hasnain; R J Kaufman; K V Ramaiah
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

7.  Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc.

Authors:  I B Rosenwald; D B Rhoads; L D Callanan; K J Isselbacher; E V Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor.

Authors:  W J Tao; H Lin; T Sun; A K Samanta; R Arlinghaus
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

9.  The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties.

Authors:  G N Barber; S Thompson; T G Lee; T Strom; R Jagus; A Darveau; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

Authors:  E F Meurs; J Galabru; G N Barber; M G Katze; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  9 in total

1.  The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis.

Authors:  Armen Parsyan; David Shahbazian; Yvan Martineau; Emmanuel Petroulakis; Tommy Alain; Ola Larsson; Geraldine Mathonnet; Gritta Tettweiler; Christopher U Hellen; Tatyana V Pestova; Yuri V Svitkin; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

2.  Simvastatin represses protein synthesis in the muscle-derived C₂C₁₂ cell line with a concomitant reduction in eukaryotic initiation factor 2B expression.

Authors:  Alexander P Tuckow; Sarah J Jefferson; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-01-11       Impact factor: 4.310

Review 3.  Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.

Authors:  Craig A Goodman; David L Mayhew; Troy A Hornberger
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

4.  Regulation of the unfolded protein response by eif2Bdelta isoforms.

Authors:  Leenus Martin; Scot R Kimball; Lawrence B Gardner
Journal:  J Biol Chem       Date:  2010-08-13       Impact factor: 5.157

5.  Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Authors:  Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Jennifer Altomonte; Alexandra Junger; Günter Schneider; Wolfgang E Thasler; Nobuyuki Kato; Roland M Schmid; Oliver Ebert
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

Review 6.  Targeting Protein Synthesis in Colorectal Cancer.

Authors:  Stefanie Schmidt; Sarah Denk; Armin Wiegering
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

7.  Genetic responses of inbred chicken lines illustrate importance of eIF2 family and immune-related genes in resistance to Newcastle disease virus.

Authors:  Ana Paula Del Vesco; Michael G Kaiser; Melissa S Monson; Huaijun Zhou; Susan J Lamont
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

Review 8.  Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.

Authors:  Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Félix Scholtes; Bernard Rogister; Natacha Coppieters
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

Review 9.  Eukaryotic translation initiation factors as promising targets in cancer therapy.

Authors:  Peiqi Hao; Jiaojiao Yu; Richard Ward; Yin Liu; Qiao Hao; Su An; Tianrui Xu
Journal:  Cell Commun Signal       Date:  2020-11-04       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.